Over the trailing 12 months, CGEN insiders sold $118,279 worth of shares (47.88K shares) in open-market trades, with no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David Silberman | Chief Financial Officer | 55,000 | 0 | 55,000 | 19.4% | 30 Jul, 2026 |
| 2 | Zurit Levine | Svp, Business Development | 47,375 | 0 | 47,375 | 16.8% | 30 Jul, 2026 |
| 3 | Russo Sharon Kredo | Svp, Research Discovery | 37,500 | 0 | 37,500 | 13.3% | 30 Jul, 2026 |
| 4 | Michelle Mahler | Chief Medical Officer | 36,625 | 0 | 36,625 | 13.0% | 30 Jul, 2026 |
| 5 | Savitzky Kinneret Livnat | Director | 20,850 | 0 | 20,850 | 7.4% | 30 Jul, 2026 |
| 6 | Sanford S Zweifach | Director | 20,180 | 0 | 20,180 | 7.1% | 30 Jul, 2026 |
| 7 | Gilead Halevy | Director | 18,907 | 0 | 18,907 | 6.7% | 30 Jul, 2026 |
| 8 | Eran Perry | Director | 17,500 | 0 | 17,500 | 6.2% | 30 Jul, 2026 |
| 9 | Mathias Hukkelhoven | Director | 17,500 | 0 | 17,500 | 6.2% | 30 Jul, 2026 |
| 10 | Eran Ophir | President And Ceo | 11,375 | 0 | 11,375 | 4.0% | 27 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 29 Jul, 2026 | Eran Perry | Director | Acquired A | 7,500 | $0.00 | $0 | 17,500 | Direct |
| 29 Jul, 2026 | Mathias Hukkelhoven | Director | Acquired A | 7,500 | $0.00 | $0 | 17,500 | Direct |
| 29 Jul, 2026 | Russo Sharon Kredo | Svp, Research Discovery | Acquired A | 18,000 | $0.00 | $0 | 37,500 | Direct |
| 29 Jul, 2026 | Savitzky Kinneret Livnat | Director | Acquired A | 7,500 | $0.00 | $0 | 20,850 | Direct |
| 29 Jul, 2026 | Eran Ophir | President And Ceo | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |
| 29 Jul, 2026 | Michelle Mahler | Chief Medical Officer | Acquired A | 13,500 | $0.00 | $0 | 36,625 | Direct |
| 29 Jul, 2026 | Pierre Ferre | Chief Operating Officer | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 29 Jul, 2026 | Zurit Levine | Svp, Business Development | Acquired A | 18,000 | $0.00 | $0 | 47,375 | Direct |
| 29 Jul, 2026 | Gilead Halevy | Director | Acquired A | 7,500 | $0.00 | $0 | 18,907 | Direct |
| 29 Jul, 2026 | David Silberman | Chief Financial Officer | Acquired A | 19,500 | $0.00 | $0 | 55,000 | Direct |
| 29 Jul, 2026 | Anat Cohen-Dayag | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 29 Jul, 2026 | Sanford S Zweifach | Director | Acquired A | 7,500 | $0.00 | $0 | 20,180 | Direct |
| 29 Jul, 2026 | Sanford S Zweifach | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Russo Sharon Kredo | Svp, Research Discovery | Acquired A | 24,000 | $0.00 | $0 | 24,000 | Direct |
| 29 Jul, 2026 | David Silberman | Chief Financial Officer | Acquired A | 26,000 | $0.00 | $0 | 26,000 | Direct |
| 29 Jul, 2026 | Zurit Levine | Svp, Business Development | Acquired A | 24,000 | $0.00 | $0 | 24,000 | Direct |
| 29 Jul, 2026 | Eran Perry | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Gilead Halevy | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Mathias Hukkelhoven | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Michelle Mahler | Chief Medical Officer | Acquired A | 18,000 | $0.00 | $0 | 18,000 | Direct |